The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Home
>
Connecticut
>
Cheshire
>
Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Inc

  • Contact Person: Scott Phillips
  • Contact Phone: 203-272-8250
  • Contact Email: PHILLIPSS@ALXN.COM
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Industries Served: Biological Product (except Diagnostic) Manufacturing
  • Product Areas: DRUGS AND BIOLOGICALS

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $85,570 - Tuesday the 18th of September 2012
    Veterans Affairs Department
    673-TAMPA
    SOLIRIS
  • $80,071 - Tuesday the 15th of November 2011
    Veterans Affairs Department
    262-NETWORK CONTRACT OFFICE 22
    PHARMACEUTICAL DRUGS (PT. MEDICATION) - SOLIRIS 300MG, VIALS
  • $36,673 - Friday the 15th of June 2012
    Veterans Affairs Department
    598-NORTH LITTLE ROCK
    SOLORIS VIALS
  • $36,673 - Friday the 20th of July 2012
    Veterans Affairs Department
    598-NORTH LITTLE ROCK
    SOLORIS 300MG/VIAL
  • $36,673 - Tuesday the 8th of May 2012
    Veterans Affairs Department
    598-NORTH LITTLE ROCK
    SOLORIS 300MG/VIAL
  • $34,307 - Wednesday the 14th of December 2011
    Veterans Affairs Department
    673-TAMPA
    MEDICAL DRUG
  • $34,307 - Thursday the 6th of October 2011
    Veterans Affairs Department
    598-NORTH LITTLE ROCK
    CHEMO-SOLORIS
  • $24,449 - Tuesday the 28th of February 2012
    Veterans Affairs Department
    598-NORTH LITTLE ROCK
    SOLORIS
  • $24,449 - Friday the 13th of January 2012
    Veterans Affairs Department
    598-NORTH LITTLE ROCK
    SOLORIS - CHEMO
  • $24,449 - Friday the 10th of February 2012
    Veterans Affairs Department
    598-NORTH LITTLE ROCK
    SOLORIS

© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.